🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in the EU / 2025-521729-33-00
Completed Phase I

C5951001- A Phase 1 Study of PF-08046876 in Participants with Advanced Solid Tumors.

2025-521729-33-00 · tracked via the Priya Life Science EU tracker
Sponsor
Pfizer Inc.
Sponsor type
Pharmaceutical company
Therapeutic area
Neoplasms
Decision date
23/12/2025
Enrollment target
70
Sites
Spain

Condition studied

advanced solid tumors

Eligibility

Age group
65+ years, 18-64 years
Sex
Female, Male
Official registry record

This page summarises publicly available CTIS data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View 2025-521729-33-00 on CTIS ↗ ← All trials in the EU